Quantitative analysis of the impact of membrane permeability on intestinal first‐pass metabolism of CYP3A substrates
Biopharmaceutics & Drug Disposition · 2024
DOI: 10.1002/bdd.2379 ↗At a glance
Journal article in Biopharmaceutics & Drug Disposition, 2024. Written by Yugo Yasugi and 2 co-authors. Institution: Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan. Major MEDLINE topics: Cytochrome P-450 CYP3A, Intestinal Absorption. Cited 1 times so far (Crossref); 30 references. Funded by: Japan Society for the Promotion of Science, JST SPRING.
Abstract (original language)
The aim of this study was firstly to investigate the effect of membrane permeability on the intestinal availability ( F g ) of 10 cytochrome P450 3A4 substrates with differing permeability ( P app ) and metabolic activity ( CL int ) using Madin‐Darby canine kidney II (MDCKII) cells expressing human CYP3A4 (MDCKII/CYP3A4 cells), and secondly to confirm the essential factors by simulations. A membrane permeation assay using MDCKII/CYP3A4 cells showed a significant correlation between human intestinal extraction ratio (ER) ( E g (=1 − F g )) and in vitro cellular ER ( r = 0.834). This relationship afforded better predictability of E g values than the relationship between E g and CL int,HIM values obtained from human intestinal microsomes ( r = 0.598). An even stronger correlation was observed between 1 − F a · F g and ER ( r = 0.874). Simulation with a cellular kinetic model indicated that ER is sensitive to changes of PS passive and CL int values, but not to the intracellular unbound fraction ( f u,cell ) or P‐gp‐mediated efflux ( PS P − gp ). It may be concluded that, based on the concentration–time profile of drugs in epithelial cells, transmembrane permeability influences F g (or ER) and drug exposure time to metabolizing enzymes for P450 substrate.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
ORCID profiles: Yugo Yasugi
Funding
- Japan Society for the Promotion of Science
- JST SPRING
Cite
APA
Yasugi, Y., Shirasaka, Y., & Tamai, I. (2024). Quantitative analysis of the impact of membrane permeability on intestinal first‐pass metabolism of CYP3A substrates. Biopharmaceutics & Drug Disposition. https://doi.org/10.1002/bdd.2379
Vancouver
Yasugi Y, Shirasaka Y, Tamai I. Quantitative analysis of the impact of membrane permeability on intestinal first‐pass metabolism of CYP3A substrates. Biopharmaceutics & Drug Disposition. 2024. doi:10.1002/bdd.2379
BibTeX
@article{Yasugi2024,
author = {Yasugi, Yugo and Shirasaka, Yoshiyuki and Tamai, Ikumi},
title = {Quantitative analysis of the impact of membrane permeability on intestinal first‐pass metabolism of CYP3A substrates},
journal = {Biopharmaceutics & Drug Disposition},
year = {2024},
doi = {10.1002/bdd.2379}
}
EUVIMED